Table of Contents Table of Contents
Previous Page  883 / 1096 Next Page
Information
Show Menu
Previous Page 883 / 1096 Next Page
Page Background

S867

ESTRO 36

_______________________________________________________________________________________________

along SOBP dose profiles were predicted also for depth

positions where experimental data were not available. A

formula was also derived to predict cell death and

chromosome damage for a different cell line exposed to a

given ion type and energy, basing on the response of a

reference cell line to the same radiation quality. For both

endpoints, the increase of effectiveness along the plateau

was quantified. A non-negligible increase was found also

for protons, associated to high levels of damage beyond

the distal dose fall-off, due to the lower energy and thus

the higher biological effectiveness.

Conclusion

In line with other studies, this work suggests that assuming

a constant RBE along a proton SOBP may be sub-optimal.

More generally, this work represents an example of

therapeutic beam characterization avoiding the use of

experimental RBE values, which can be source of

uncertainties.

Acknowledgements:

this work was partially supported by

INFN (project ETHICS, P.I. L. Manti, local P.I. F. Ballarini;

MC-INFN/FLUKA, P.I. P. Sala, local P.I. A. Fontana)

EP-1607 Secondary cancer risk after particle therapy

for organs distal or lateral to the target volume

L. Toussaint

1

, L. Muren

1

, G. Engeseth

2

, C. Stokkevåg

2

1

Aarhus University Hospital, Medical Physics, Aarhus C,

Denmark

2

Haukeland University Hospital, Department of Oncology

and Medical Physics, Bergen, Norway

Purpose or Objective

Proton therapy is the most used particle therapy modality,

but carbon ions are also increasingly being applied for

specific tumour entities. Particle therapy in general has a

known potential of reducing the irradiated volumes of

normal tissues, although protons and carbon ions have

distinctively different dose distribution characteristics.

Protons have a steeper dose fall-off distally while carbon

ions have a sharper lateral dose penumbra. In addition,

carbon ions have a higher biological effect due to

increased cell inactivation, but also for the end-point cell

mutation associated with carcinogenic potential. The aim

of this study was therefore to compare the risk of

secondary cancer (SC) from dose distributions in the

thyroid and lungs, particularly radiosensitive organs

located distally and laterally to the target volume during

craniospinal irradiation (CSI). Since pre-clinical data

indicates that the carbon ions RBE for cell mutation may

be higher than for cell inactivation, we included this in the

models.

Material and Methods

CSI treatment plans with a prescribed dose of 23.4Gy(RBE)

were generated on CT-scans from six pediatric patients

(Syngo, Siemens) using pencil beam scanning protons

(IMPT) and carbon ions (C-ions). Relative risks (RRs) of

radiation induced cancer (IMPT/C-ions) for the thyroid and

the lungs were analysed by applying a bell-shaped dose-

response model (J Radiol Prot 2009; 29(2A): A143-157).

The model accounts for RBE, fractionation as well as for

the competing events of cell mutation and inactivation.

The RBE variation for the different end-points was

included by introducing and varying the ratio (k) between

cell mutation and inactivation for C-ions. The median and

range of the patient-specific RRs were calculated from the

physical dose distributions and the published input model

parameters.

Results

The dose distributions (Fig 1) illustrated the sharper

lateral penumbra of C-ions, which resulted in lower lung

doses compared to protons, while the C-ion fragmentation

tail contributed to higher doses to the thyroid than from

protons. The SC risk estimates strongly depended on the

ratio k, and the RR decreased for increasing k for both

organs (Fig 2). For the thyroid, the RR was higher from the

C-ion plans for the entire scanned range of k. Despite a

better sparing of the lungs with C-ions, the carcinogenic

potential of C-ions was not consistently lower than for

protons: Not including a difference in end-point resulted

in RRs in favour of C-ions, while increasing the ratio k gave

higher risks for C-ions compared to protons. For the lungs,

the median RR turned in favour of IMPT at a threshold

value

k=1.1.